Drug-resistant Staph becoming a crisis

NEW YORK -- When scientists sounded an alarm last week about the evolving presence of methicillin-resistant Staphylococcus aureus — MRSA — they shed new light on an old problem about a bug that has been evading destruction since the dawn of the antibiotic era.

Their conclusion: MRSA is here to stay. It is an organism that can cause mild skin infections but is capable of invading the bloodstream and causing systemic damage. For years it has been a problem in hospitals, a so-called nosocomial infection. Now it is making its way into communities, infecting people in gyms, schools and daycare centers.

MRSA is a threat because it is drug-resistant — and hardy. But it has plenty of company among microbes — tiny creatures with titanic drug-repelling consequences. Indeed, MRSA got its name, methicillin-resistant Staphylococcus aureus, because it is capable of defeating methicillin, penicillin’s more potent cousin.

“What we have seen is Darwinism in action,” said Dr. Roy Steigbigel of Stony Brook University Medical Center, referring to MRSA’s drug-thwarting capacity as a prime example of survival of the fittest.

The trouble with drug-resistant organisms is frightening: The medical community is running out of drugs to control them.

Subscribe to The China Post and save.  Click hereSharePrintEmail
Write a Comment



CAPTCHA Code Image
Change the code
 Receive China Post promos Respond to this email
Subscribe  |   Advertise  |   RSS Feed  |   About Us  |   Career  |   Contact Us
Sitemap  |   Top Stories  |   Taiwan  |   China  |   Business  |   Asia  |   World  |   Sports  |   Life  |   Arts & Leisure  |   Health  |   Editorial  |   Commentary
Travel  |   Movies  |   TV Guide  |   Classifieds  |   Bookstore  |   Getting Around  |   Weather  |   Guide Post  |   Student Post  |   English Courses  |   Terms of Use  |   Sitemap